October 5, 2021

Tuesday, October 5, 2021

by Gist Healthcare

https://ssl-static.libsyn.com/p/assets/a/8/f/4/a8f4f9574ef29061/gist-podcast-banner_1_1.png

Listen Time: 06:51

Merck’s new antiviral pill to treat COVID-19 shows a lot of promise. CMS lays out how the No Surprises Act dispute resolution process will work. And non-covid research is still lagging behind pre-pandemic levels.